139 related articles for article (PubMed ID: 19296526)
1. Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer.
Albers AE; Schaefer C; Visus C; Gooding W; DeLeo AB; Whiteside TL
Head Neck; 2009 Jun; 31(6):773-81. PubMed ID: 19296526
[TBL] [Abstract][Full Text] [Related]
2. Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck.
Kim JW; Tsukishiro T; Johnson JT; Whiteside TL
Clin Cancer Res; 2004 Aug; 10(15):5101-10. PubMed ID: 15297413
[TBL] [Abstract][Full Text] [Related]
3. Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.
Hoffmann TK; Donnenberg AD; Finkelstein SD; Donnenberg VS; Friebe-Hoffmann U; Myers EN; Appella E; DeLeo AB; Whiteside TL
Cancer Res; 2002 Jun; 62(12):3521-9. PubMed ID: 12067999
[TBL] [Abstract][Full Text] [Related]
4. Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck.
Kuss I; Donnenberg AD; Gooding W; Whiteside TL
Br J Cancer; 2003 Jan; 88(2):223-30. PubMed ID: 12610507
[TBL] [Abstract][Full Text] [Related]
5. Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer.
Tsukishiro T; Donnenberg AD; Whiteside TL
Cancer Immunol Immunother; 2003 Oct; 52(10):599-607. PubMed ID: 12827303
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
[TBL] [Abstract][Full Text] [Related]
7. Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites.
Albers AE; Ferris RL; Kim GG; Chikamatsu K; DeLeo AB; Whiteside TL
Cancer Immunol Immunother; 2005 Nov; 54(11):1072-81. PubMed ID: 15959774
[TBL] [Abstract][Full Text] [Related]
8. The immune signature of CD8(+)CCR7(+) T cells in the peripheral circulation associates with disease recurrence in patients with HNSCC.
Czystowska M; Gooding W; Szczepanski MJ; Lopez-Abaitero A; Ferris RL; Johnson JT; Whiteside TL
Clin Cancer Res; 2013 Feb; 19(4):889-99. PubMed ID: 23363813
[TBL] [Abstract][Full Text] [Related]
9. Chemokine C receptor 7 expression and protection of circulating CD8+ T lymphocytes from apoptosis.
Kim JW; Ferris RL; Whiteside TL
Clin Cancer Res; 2005 Nov; 11(21):7901-10. PubMed ID: 16278415
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the T-cell receptor variable beta gene-restricted profile of CD8+ T lymphocytes in the peripheral circulation of patients with squamous cell carcinoma of the head and neck.
Albers AE; Visus C; Tsukishiro T; Ferris RL; Gooding W; Whiteside TL; De Leo AB
Clin Cancer Res; 2006 Apr; 12(8):2394-403. PubMed ID: 16638844
[TBL] [Abstract][Full Text] [Related]
11. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
[TBL] [Abstract][Full Text] [Related]
12. p53 as an immunotherapeutic target in head and neck cancer.
Hoffmann TK; Bier H; Donnenberg AD; Whiteside TL; De Leo AB
Adv Otorhinolaryngol; 2005; 62():151-60. PubMed ID: 15608425
[TBL] [Abstract][Full Text] [Related]
13. Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer.
Albers AE; Qian X; Kaufmann AM; Mytilineos D; Ferris RL; Hoffmann TK; DeLeo AB
Sci Rep; 2018 Jul; 8(1):10716. PubMed ID: 30013227
[TBL] [Abstract][Full Text] [Related]
14. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma.
Saito T; Dworacki G; Gooding W; Lotze MT; Whiteside TL
Clin Cancer Res; 2000 Apr; 6(4):1351-64. PubMed ID: 10778963
[TBL] [Abstract][Full Text] [Related]
16. gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells.
Walker EB; Haley D; Miller W; Floyd K; Wisner KP; Sanjuan N; Maecker H; Romero P; Hu HM; Alvord WG; Smith JW; Fox BA; Urba WJ
Clin Cancer Res; 2004 Jan; 10(2):668-80. PubMed ID: 14760090
[TBL] [Abstract][Full Text] [Related]
17. Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex.
Hoffmann TK; Donnenberg VS; Friebe-Hoffmann U; Meyer EM; Rinaldo CR; DeLeo AB; Whiteside TL; Donnenberg AD
Cytometry; 2000 Dec; 41(4):321-8. PubMed ID: 11084618
[TBL] [Abstract][Full Text] [Related]
18. The tumor antigens RHAMM and G250/CAIX are expressed in head and neck squamous cell carcinomas and elicit specific CD8+ T cell responses.
Schmitt A; Barth TF; Beyer E; Borchert F; Rojewski M; Chen J; Guillaume P; Gronau S; Greiner J; Möller P; Riechelmann H; Schmitt M
Int J Oncol; 2009 Mar; 34(3):629-39. PubMed ID: 19212667
[TBL] [Abstract][Full Text] [Related]
19. Kv1.3 Channels Mark Functionally Competent CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer.
Chimote AA; Hajdu P; Sfyris AM; Gleich BN; Wise-Draper T; Casper KA; Conforti L
Cancer Res; 2017 Jan; 77(1):53-61. PubMed ID: 27815390
[TBL] [Abstract][Full Text] [Related]
20. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]